AbbVie
ADC Therapeutics
BeiGene
Bristol Myers Squibb
GlaxoSmithKline
Innovent
Merck
Morphosys
Ono Pharmaceutical
Pfizer
Roche
Seagen
Takeda Pharmaceuticals
Published | Pages | Publisher | Report code |
---|---|---|---|
May 2022 | 420 | Kuick Research | ASDR-600010 |
AbbVie
ADC Therapeutics
BeiGene
Bristol Myers Squibb
GlaxoSmithKline
Innovent
Merck
Morphosys
Ono Pharmaceutical
Pfizer
Roche
Seagen
Takeda Pharmaceuticals